FOR IMMEDIATE RELEASE
July 5, 2007
New
Statute Extends Sunshine Law Coverage to
Panel
Overseeing Medicaid Drugs
(
Sen. Erickson inserted an amendment into House Bill 1367 which will require
that the Pharmaceutical and Therapeutics Committee in the Department of Public
Welfare conduct its meetings in accordance with the state Sunshine Act.
As a result, all meetings of that committee, including those at which votes are
taken, must be open to the public, with advance public notice.
The Pharmaceutical and Therapeutics Committee, whose members are selected by
the Pennsylvania Department of Public Welfare, reviews and makes
recommendations on which drugs will be available to Medical Assistance
recipients. These recommendations can have dramatic consequences both for the
health of patients and the cost to taxpayers.
“My Senate colleagues and I have worked throughout this session to make
government more open and accountable. Certainly, any stateappointed
entity that influences which drugs are available and paid for under the Medical
Assistance Program should conduct its business under rules that will ensure
public notice and input,” Sen. Erickson said. “The Senate has also passed
legislation to increase the fines for violating the Sunshine Law, and we are
putting a host of legislative information online for public viewing. This is
one more step in our ongoing effort to make government more transparent.”
###